Alex Yang

Amministratore Delegato presso POLARYX THERAPEUTICS, INC.

Patrimonio netto: 74 M $ in data 31/05/2026

56 anni

Commercial Services

Consumer Services

Health Technology

Profilo

Alex Yang is currently Chairman & Chief Executive Officer at Polaryx Therapeutics, Inc. since 2023, Chairman & Chief Executive Officer at Epygenix Therapeutics, Inc., and Chief Executive Officer at Mstone Partners Hong Kong Ltd. Formerly, Mr. Yang was Managing Partner at Kim & Chang.
Education includes undergraduate studies at State University of New York at Binghamton and graduate studies at New York University School of Law.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valutazione	Data di valutazione
POLARYX THERAPEUTICS, INC. 48,04%	27/05/2026	22.744.796 ( 48,04% )	74 M $	31/05/2026

Posizioni attive di Alex Yang

Società	Posizione	Inizio
POLARYX THERAPEUTICS, INC.	Amministratore Delegato	01/03/2023
Epygenix Therapeutics, Inc. Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders	Amministratore Delegato	-
Mstone Partners Hong Kong Ltd.	Amministratore Delegato	-

Tutte le posizioni attive di Alex Yang

Precedenti posizioni note di Alex Yang

Società	Posizione	Fine
Kim & Chang Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Alex Yang

Formazione di Alex Yang

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Alex Yang

Società collegate

Aziende private	6
Kim & Chang Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services	Commercial Services
State University of New York at Binghamton State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University School of Law New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mstone Partners Hong Kong Ltd.
Epygenix Therapeutics, Inc. Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders	Health Technology
Polaryx Therapeutics, Inc. Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders	Commercial Services